NUTX
Nutex Health Inc.
Price Chart
Latest Quote
$147.23
-2.94 (-1.96%)
Current Price
| Previous Close | $150.17 |
| Open | $147.97 |
| Day High | $153.70 |
| Day Low | $146.21 |
| Volume | 97,882 |
Stock Information
| Shares Outstanding | 6.88M |
| Total Debt | $349.09M |
| Cash Equivalents | $207.35M |
| Revenue | $879.95M |
| Net Income | $96.38M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $1.01B |
| P/E Ratio | 10.77 |
| EPS (TTM) | $13.67 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.27B |
| Sales | $879.95M |
| Income | $96.38M |
| Book/sh | $49.81 |
| Cash/sh | $30.13 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 3.00 |
| Current Ratio | 3.14 |
| Debt/Eq | 78.97 |
| EPS Growth TTM | 120.60% |
Returns & Margins
| ROA | 28.59% |
| ROE | 53.65% |
| Gross Margin | 50.58% |
| Operating Margin | 37.54% |
| Profit Margin | 10.95% |
Ownership
| Insider Ownership | 29.06% |
| Institutional Ownership | 42.53% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 7.24 |
| P/S | 1.15 |
| P/B | 2.96 |
Analyst Data
| Recommendation | none |
| Target Price | $235.50 |
Technical Indicators
| SMA20 | $136.81 |
| SMA50 | $126.79 |
| SMA200 | $123.62 |
| RSI | 72.81 |
| ATR | 7.3346 |
| Shares Float | 4.22M |
| Short Float | 24.47% |
| Short Ratio | 6.59 |
| Volatility | 2.06 |
| Rel Volume | 0.75 |
Performance History
| Week | +0.10% |
| Month | +23.85% |
| Quarter | +55.01% |
| 6 Months | -11.75% |
| YTD | -0.65% |
| Year | +29.27% |
| 3 Years | +140.57% |
| 10 Years | -97.55% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $147.23 | 97,882 |
| 2026-06-22 | $150.17 | 155,300 |
| 2026-06-18 | $150.51 | 144,400 |
| 2026-06-17 | $146.38 | 59,400 |
| 2026-06-16 | $144.04 | 69,500 |
| 2026-06-15 | $147.08 | 77,800 |
| 2026-06-12 | $144.40 | 87,000 |
| 2026-06-11 | $147.01 | 174,400 |
| 2026-06-10 | $133.61 | 207,200 |
| 2026-06-09 | $135.40 | 110,300 |
| 2026-06-08 | $134.41 | 108,200 |
| 2026-06-05 | $132.59 | 131,500 |
| 2026-06-04 | $135.10 | 122,500 |
| 2026-06-03 | $132.83 | 150,200 |
| 2026-06-02 | $125.03 | 173,900 |
| 2026-06-01 | $128.02 | 142,300 |
| 2026-05-29 | $129.11 | 123,700 |
| 2026-05-28 | $130.58 | 199,800 |
| 2026-05-27 | $119.45 | 116,400 |
| 2026-05-26 | $123.20 | 152,300 |
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
đ° Latest News
3 Undervalued Small Caps With Insider Action Across Regions
Simply Wall St. âĸ 2026-06-02T11:39:57Z
Nutex Health NUTX Q2 2025 Earnings Transcript
Motley Fool âĸ 2026-05-04T15:51:49Z
Explore These 3 Undervalued Small Caps With Insider Buying Across Regions
Simply Wall St. âĸ 2026-05-04T11:40:06Z
Nutex Health And 2 Other Undiscovered Gems In The US Market
Simply Wall St. âĸ 2026-05-04T11:33:21Z
A Look At Nutex Health (NUTX) Valuation After Strong Q1 2026 Results And New Buyback Program
Simply Wall St. âĸ 2026-05-04T07:07:55Z
Nutex Health Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-01T16:52:40Z
Nutex Health, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-01T12:30:00Z
Nutex Health Annual Meeting: Shareholders Elect Directors, Approve Say-on-Pay and Auditor Ratification
MarketBeat âĸ 2026-04-25T17:02:42Z
US Market's Hidden Treasures 3 Promising Small Caps With Strong Potential
Simply Wall St. âĸ 2026-04-03T17:33:30Z
Exploring Three Undervalued Small Caps With Insider Action Across Regions
Simply Wall St. âĸ 2026-04-03T11:39:34Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $430,976,000 | $283,687,000 | $212,872,000 | $203,872,568 |
| Cost Of Revenue | $430,976,000 | $283,687,000 | $212,872,000 | $203,872,568 |
| Total Revenue | $875,257,000 | $479,949,000 | $247,646,000 | $219,294,306 |
| Operating Revenue | $875,257,000 | $479,949,000 | $247,646,000 | $219,294,306 |
| Expenses | ||||
| Interest Expense | $22,226,000 | $19,932,000 | $16,318,000 | $12,490,260 |
| Total Expenses | $599,632,000 | $342,166,000 | $249,155,000 | $223,872,756 |
| Other Income Expense | $-8,618,000 | $-8,024,000 | $-30,664,000 | $-402,580,003 |
| Other Non Operating Income Expenses | $-8,618,000 | $669,000 | $-399,000 | $-559,299 |
| Net Non Operating Interest Income Expense | $-22,226,000 | $-19,932,000 | $-16,318,000 | $-12,490,260 |
| Interest Expense Non Operating | $22,226,000 | $19,932,000 | $16,318,000 | $12,490,260 |
| Operating Expense | $168,656,000 | $58,479,000 | $36,283,000 | $20,000,188 |
| General And Administrative Expense | $168,656,000 | $58,479,000 | $36,066,000 | $20,000,188 |
| Other Operating Expenses | - | - | $217,000 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $70,789,000 | $52,097,000 | $-45,787,000 | $-424,780,446 |
| Net Interest Income | $-22,226,000 | $-19,932,000 | $-16,318,000 | $-12,490,260 |
| Normalized Income | $70,789,000 | $59,601,130 | $-18,684,499 | $-107,184,090 |
| Net Income From Continuing And Discontinued Operation | $70,789,000 | $52,097,000 | $-45,787,000 | $-424,780,446 |
| Total Operating Income As Reported | $275,625,000 | $130,698,000 | $-31,774,000 | $-406,599,154 |
| Net Income Common Stockholders | $70,789,000 | $52,097,000 | $-45,787,000 | $-424,780,446 |
| Net Income | $70,789,000 | $52,097,000 | $-45,787,000 | $-424,780,446 |
| Net Income Including Noncontrolling Interests | $180,357,000 | $94,806,000 | $-43,424,000 | $-432,739,618 |
| Net Income Continuous Operations | $180,357,000 | $94,806,000 | $-43,424,000 | $-432,739,618 |
| Pretax Income | $244,781,000 | $109,826,000 | $-48,491,000 | $-419,648,713 |
| Special Income Charges | $0 | $-7,084,000 | $-30,265,000 | $-402,020,704 |
| Operating Income | $275,625,000 | $137,782,000 | $-1,509,000 | $-4,578,450 |
| Gross Profit | $444,281,000 | $196,261,000 | $34,774,000 | $15,421,738 |
| Average Dilution Earnings | - | $1,131,287 | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $10.48 | $9.71 | $-10.50 | $-100.50 |
| Basic EPS | $11.13 | $10.25 | $-10.50 | $-100.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-1,188,870 | $-3,162,499 | $-84,424,348 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $287,537,000 | $157,423,000 | $15,684,000 | $7,993,625 |
| Total Unusual Items | $0 | $-8,693,000 | $-30,265,000 | $-402,020,704 |
| Total Unusual Items Excluding Goodwill | $0 | $-8,693,000 | $-30,265,000 | $-402,020,704 |
| Reconciled Depreciation | $20,530,000 | $18,972,000 | $17,592,000 | $13,131,374 |
| EBITDA (Bullshit earnings) | $287,537,000 | $148,730,000 | $-14,581,000 | $-394,027,079 |
| EBIT | $267,007,000 | $129,758,000 | $-32,173,000 | $-407,158,453 |
| Diluted Average Shares | $6,756,108 | $5,373,756 | $4,360,630 | $4,226,671 |
| Basic Average Shares | $6,361,427 | $5,090,651 | $4,360,630 | $4,226,671 |
| Diluted NI Availto Com Stockholders | $70,789,000 | $52,097,000 | $-45,787,000 | $-424,780,446 |
| Minority Interests | $-109,568,000 | $-42,709,000 | $-2,363,000 | $7,959,172 |
| Tax Provision | $64,424,000 | $15,020,000 | $-5,067,000 | $13,090,905 |
| Write Off | $0 | $3,887,000 | $29,082,000 | $0 |
| Impairment Of Capital Assets | $0 | $3,197,000 | $1,139,000 | $398,135,038 |
| Restructuring And Mergern Acquisition | $0 | $0 | $44,000 | $3,885,666 |
| Selling General And Administration | $168,656,000 | $58,479,000 | $36,066,000 | $20,000,188 |
| Other Gand A | $51,653,000 | $41,924,000 | $33,230,000 | $19,810,607 |
| Salaries And Wages | $117,003,000 | $16,555,000 | $2,836,000 | $189,581 |
| Gain On Sale Of Security | - | $-1,609,000 | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $294,298,000 | $102,990,000 | $23,874,291 | $57,660,674 |
| Total Assets | $918,525,000 | $655,320,000 | $398,245,497 | $431,751,985 |
| Total Non Current Assets | $379,714,000 | $362,841,000 | $307,397,094 | $333,778,061 |
| Other Non Current Assets | $662,000 | $711,000 | $431,135 | $423,426 |
| Non Current Deferred Assets | $0 | $7,987,000 | $0 | - |
| Non Current Deferred Taxes Assets | $0 | $7,987,000 | $0 | - |
| Goodwill And Other Intangible Assets | $35,149,000 | $29,449,000 | $37,578,899 | $38,202,027 |
| Other Intangible Assets | $21,230,000 | $15,530,000 | $20,512,636 | $21,191,390 |
| Current Assets | $538,811,000 | $292,479,000 | $90,848,403 | $97,973,924 |
| Other Current Assets | $24,656,000 | $9,997,000 | $2,679,394 | $1,869,806 |
| Restricted Cash | $297,000 | $2,941,000 | $0 | - |
| Inventory | $2,866,000 | $2,850,000 | $3,390,584 | $3,533,285 |
| Receivables | $325,418,000 | $236,051,000 | $62,776,369 | $58,315,569 |
| Accounts Receivable | $325,418,000 | $236,051,000 | $62,776,369 | $58,315,569 |
| Cash Cash Equivalents And Short Term Investments | $185,574,000 | $40,640,000 | $22,002,056 | $34,255,264 |
| Cash And Cash Equivalents | $185,574,000 | $40,640,000 | $22,002,056 | $34,255,264 |
| Debt | ||||
| Total Debt | $351,393,000 | $340,296,000 | $275,756,948 | $267,201,513 |
| Long Term Debt And Capital Lease Obligation | $328,088,000 | $312,562,000 | $255,680,585 | $246,109,405 |
| Long Term Debt | $29,174,000 | $22,466,000 | $26,314,733 | $23,051,152 |
| Current Debt And Capital Lease Obligation | $23,305,000 | $27,734,000 | $20,076,363 | $21,092,108 |
| Current Debt | $14,076,000 | $17,949,000 | $14,180,397 | $15,169,576 |
| Other Current Borrowings | $13,336,000 | $14,395,000 | $10,808,721 | $12,546,097 |
| Net Debt | - | - | $18,493,074 | $3,965,464 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $495,088,000 | $466,787,000 | $319,139,391 | $311,424,585 |
| Total Non Current Liabilities Net Minority Interest | $337,177,000 | $312,562,000 | $260,826,339 | $256,561,616 |
| Non Current Deferred Liabilities | $9,089,000 | $0 | $5,145,754 | $10,452,211 |
| Non Current Deferred Taxes Liabilities | $9,089,000 | $0 | $5,145,754 | $10,452,211 |
| Current Liabilities | $157,911,000 | $154,225,000 | $58,313,052 | $54,862,969 |
| Payables And Accrued Expenses | $126,350,000 | $110,135,000 | $38,236,689 | $33,770,861 |
| Payables | $51,724,000 | $38,083,000 | $25,680,062 | $27,530,048 |
| Total Tax Payable | $2,757,000 | $27,663,000 | $398,669 | $1,029,790 |
| Income Tax Payable | $867,000 | $26,533,000 | $0 | - |
| Accounts Payable | $48,967,000 | $10,420,000 | $25,281,393 | $27,530,048 |
| Equity | ||||
| Common Stock Equity | $329,447,000 | $132,439,000 | $61,453,190 | $95,862,701 |
| Total Equity Gross Minority Interest | $423,437,000 | $188,533,000 | $79,106,106 | $120,327,400 |
| Stockholders Equity | $329,447,000 | $132,439,000 | $61,453,190 | $95,862,701 |
| Retained Earnings | $-286,187,000 | $-356,976,000 | $-409,072,539 | $-363,285,925 |
| Other | ||||
| Ordinary Shares Number | $7,086,670 | $5,511,452 | $4,511,199 | $4,334,825 |
| Share Issued | $7,086,670 | $5,511,452 | $4,511,199 | $4,334,825 |
| Tangible Book Value | $294,298,000 | $102,990,000 | $23,874,291 | $57,660,674 |
| Invested Capital | $372,697,000 | $172,854,000 | $101,948,320 | $134,083,429 |
| Working Capital | $380,900,000 | $138,254,000 | $32,535,351 | $43,110,955 |
| Capital Lease Obligations | $308,143,000 | $299,881,000 | $235,261,818 | $228,980,785 |
| Total Capitalization | $358,621,000 | $154,905,000 | $87,767,923 | $118,913,853 |
| Minority Interest | $93,990,000 | $56,094,000 | $17,652,916 | $24,464,699 |
| Additional Paid In Capital | $615,627,000 | $489,409,000 | $470,521,218 | $458,498,402 |
| Capital Stock | $7,000 | $6,000 | $4,511 | $650,224 |
| Common Stock | $7,000 | $6,000 | $4,511 | $650,224 |
| Long Term Capital Lease Obligation | $298,914,000 | $290,096,000 | $229,365,852 | $223,058,253 |
| Current Capital Lease Obligation | $9,229,000 | $9,785,000 | $5,895,966 | $5,922,532 |
| Line Of Credit | $740,000 | $3,554,000 | $3,371,676 | $2,623,479 |
| Pensionand Other Post Retirement Benefit Plans Current | $8,256,000 | $16,356,000 | $0 | - |
| Current Accrued Expenses | $74,626,000 | $72,052,000 | $12,556,627 | $6,240,813 |
| Goodwill | $13,919,000 | $13,919,000 | $17,066,263 | $17,010,637 |
| Net PPE | $343,903,000 | $324,694,000 | $269,387,060 | $295,152,608 |
| Accumulated Depreciation | $-31,696,000 | $-25,271,000 | $-18,341,063 | $-13,011,878 |
| Gross PPE | $375,599,000 | $349,965,000 | $287,728,123 | $308,164,486 |
| Leases | $30,333,000 | $28,126,000 | $27,606,383 | $28,855,239 |
| Construction In Progress | $2,149,000 | $1,892,000 | $12,845,631 | $19,389,329 |
| Other Properties | $287,007,000 | $284,228,000 | $223,094,912 | $242,966,642 |
| Machinery Furniture Equipment | $13,730,000 | $11,659,000 | $9,900,984 | $4,709,704 |
| Buildings And Improvements | $33,816,000 | $19,650,000 | $9,878,325 | $8,521,996 |
| Land And Improvements | $8,564,000 | $4,410,000 | $4,401,888 | $3,721,576 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $245,599,000 | $20,849,000 | $-8,240,000 | $35,974,694 |
| Operating Activities | ||||
| Operating Cash Flow | $248,125,000 | $23,153,000 | $1,257,000 | $50,607,108 |
| Cash Flow From Continuing Operating Activities | $248,125,000 | $23,153,000 | $1,257,000 | $50,607,108 |
| Operating Gains Losses | - | $1,609,000 | - | $561,651 |
| Investing Activities | ||||
| Capital Expenditure | $-2,526,000 | $-2,304,000 | $-9,497,000 | $-14,632,414 |
| Investing Cash Flow | $-5,242,000 | $-5,606,000 | $-11,240,000 | $-4,337,398 |
| Cash Flow From Continuing Investing Activities | $-5,242,000 | $-5,606,000 | $-11,240,000 | $-4,337,398 |
| Net Other Investing Changes | $-4,312,000 | $-2,941,000 | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-5,000,000 | $0 | $0 | - |
| Issuance Of Capital Stock | $0 | $9,202,000 | $0 | $0 |
| Financing Cash Flow | $-97,949,000 | $1,091,000 | $-2,270,000 | $-48,132,730 |
| Cash Flow From Continuing Financing Activities | $-97,949,000 | $1,091,000 | $-2,270,000 | $-48,132,730 |
| Net Other Financing Charges | $767,000 | $3,353,000 | $298,000 | $4,513,867 |
| Cash Dividends Paid | $-74,276,000 | $-6,438,000 | $-5,215,000 | $-51,231,657 |
| Common Stock Dividend Paid | $-74,276,000 | $-6,438,000 | $-5,215,000 | $-51,231,657 |
| Net Common Stock Issuance | $-5,000,000 | $9,202,000 | $0 | $0 |
| Common Stock Issuance | $0 | $9,202,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-24,483,000 | $-16,676,000 | $-21,557,000 | $-9,030,373 |
| Issuance Of Debt | $5,043,000 | $9,277,000 | $24,204,000 | $3,439,360 |
| Interest Paid Supplemental Data | $2,508,000 | $3,472,000 | $1,639,000 | $4,622,106 |
| Income Tax Paid Supplemental Data | $72,815,000 | $799,000 | $849,000 | $8,233,000 |
| End Cash Position | $185,871,000 | $40,640,000 | $22,002,000 | $34,255,264 |
| Other Cash Adjustment Outside Changein Cash | $297,000 | $0 | $0 | - |
| Beginning Cash Position | $40,640,000 | $22,002,000 | $34,255,000 | $36,118,284 |
| Changes In Cash | $144,934,000 | $18,638,000 | $-12,253,000 | $-1,863,020 |
| Proceeds From Stock Option Exercised | $0 | $2,373,000 | $0 | $4,176,073 |
| Common Stock Payments | $-5,000,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $-19,440,000 | $-7,399,000 | $2,647,000 | $-5,591,013 |
| Net Long Term Debt Issuance | $-19,440,000 | $-7,399,000 | $2,647,000 | $-5,591,013 |
| Long Term Debt Payments | $-24,483,000 | $-16,676,000 | $-21,557,000 | $-9,030,373 |
| Long Term Debt Issuance | $5,043,000 | $9,277,000 | $24,204,000 | $3,439,360 |
| Net Investment Purchase And Sale | $1,596,000 | $0 | $0 | - |
| Sale Of Investment | $1,596,000 | $0 | $0 | - |
| Net Business Purchase And Sale | $0 | $-361,000 | $-1,743,000 | $10,295,016 |
| Purchase Of Business | $0 | $-361,000 | $-1,743,000 | $-2,421,212 |
| Net PPE Purchase And Sale | $-2,526,000 | $-2,304,000 | $-9,497,000 | $-14,632,414 |
| Purchase Of PPE | $-2,526,000 | $-2,304,000 | $-9,497,000 | $-14,632,414 |
| Change In Working Capital | $-87,743,000 | $-104,235,000 | $-1,529,000 | $64,315,901 |
| Change In Other Current Liabilities | $-508,000 | $-1,528,000 | $-1,501,000 | - |
| Change In Other Current Assets | $917,000 | $1,147,000 | $1,632,000 | - |
| Change In Payables And Accrued Expense | $15,793,000 | $76,034,000 | $3,598,000 | $8,377,080 |
| Change In Accrued Expense | $-24,062,000 | $39,011,000 | $5,846,000 | $-1,311,865 |
| Change In Payable | $39,855,000 | $37,023,000 | $-2,248,000 | $9,688,945 |
| Change In Account Payable | $37,853,000 | $-10,719,000 | $-2,248,000 | $9,688,945 |
| Change In Tax Payable | $2,002,000 | $47,742,000 | $0 | $0 |
| Change In Income Tax Payable | $2,002,000 | $47,742,000 | $0 | $0 |
| Change In Prepaid Assets | $-14,610,000 | $-7,021,000 | $-817,000 | $-1,419,139 |
| Change In Inventory | $-16,000 | $540,000 | $143,000 | $-719,107 |
| Change In Receivables | $-89,319,000 | $-173,407,000 | $-4,584,000 | $58,077,067 |
| Changes In Account Receivables | $-89,319,000 | $-173,407,000 | $-4,584,000 | $58,077,067 |
| Other Non Cash Items | $902,000 | $1,495,000 | $1,268,000 | $2,016,972 |
| Stock Based Compensation | $117,003,000 | $16,555,000 | $2,836,000 | $189,581 |
| Asset Impairment Charge | $0 | $7,084,000 | $30,221,000 | $398,135,038 |
| Deferred Tax | $17,076,000 | $-13,133,000 | $-5,707,000 | $4,996,209 |
| Deferred Income Tax | $17,076,000 | $-13,133,000 | $-5,707,000 | $4,996,209 |
| Depreciation Amortization Depletion | $20,530,000 | $18,972,000 | $17,592,000 | $13,131,374 |
| Depreciation And Amortization | $20,530,000 | $18,972,000 | $17,592,000 | $13,131,374 |
| Net Income From Continuing Operations | $180,357,000 | $94,806,000 | $-43,424,000 | $-432,739,618 |
| Net Short Term Debt Issuance | - | $182,353 | $748,197 | $2,551,424 |
| Short Term Debt Payments | - | $-2,079,390 | $-1,592,714 | $-72,055 |
| Short Term Debt Issuance | - | $2,261,743 | $2,340,911 | $2,623,479 |
| Sale Of Business | - | $0 | $0 | $12,716,228 |
| Gain Loss On Investment Securities | - | $1,609,000 | - | $561,651 |
Fetched: 2026-06-17